Komori
Premier Anti-Aging (4934) · InitiativeAdvanced

Share Issuance Through Restricted Stock Compensation

First written in FY2022-Q1. 1 of 5 entries say "Reframed", first in FY2022. Latest entry: FY2026-H1.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q1ReframedFY2022RestatedFY2023 – FY2025-H12021: 12022: 120222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 655 companies write about · 0 as a headwind · 736 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 738 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「Fourth Series of Stock Acquisition Rights. Categories and number of eligible recipients (people): company directors 1; company executive officers 2. Number of stock acquisition rights (units): 400. Class, details and number of shares underlying the stock acquisition rights (shares): common shares 40,000. Exercise period: from 14 November 2027 to 14 November 2033」

    The company disclosed the operation of incentive compensation granting 400 Fourth Series stock acquisition rights, underlying 40,000 shares, to 1 director and 2 executive officers.
  2. FY2025-H1Incentive Compensation Through Stock Acquisition RightsAnnual report

    「Number of stock acquisition rights: 900 (Note) 1. Class, details and number of shares underlying the stock acquisition rights (shares): common shares 90,000 (Note) 1. Exercise period: from 14 November 2026 to 14 November 2032」

    The company disclosed the grant terms for the Third Series of Stock Acquisition Rights, resolved on 29 October 2024, to 1 director and 5 executive officers. The disclosure additionally shows a mechanism using stock acquisition rights as incentive compensation.
  3. FY2023RestatedAnnual report

    「Directors' equity compensation is intended to function as an incentive to achieve sustained growth in corporate value and to align their interests with shareholders. Under the employee stock ownership accumulation plan, a fixed monthly amount is paid to executive directors.」

    The company continues to provide equity compensation under the employee stock ownership accumulation plan, which was changed from restricted stock compensation.
  4. FY2022ReframedAnnual report

    「At a meeting of the Board of Directors held on 13 September 2022, the company resolved to abolish restricted stock compensation and change the policy for determining directors' compensation and other benefits to equity compensation using an employee stock ownership accumulation plan.」

    The company changed its compensation scheme from restricted stock compensation to equity compensation using an employee stock ownership accumulation plan, restructuring it to avoid new share issuance costs and dilution.
  5. FY2022-Q1First statedAnnual report

    「Pursuant to a resolution of the Board of Directors dated 28 October 2021, the company issued 534 new shares as restricted stock compensation, with 26 November 2021 as the payment date.」

    For the first time, the company describes the operation of a scheme to issue 534 shares as restricted stock compensation pursuant to a resolution of the Board of Directors.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Premier Anti-Aging yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Share Issuance Through Restricted Stock Compensation | Premier Anti-Aging Co.,Ltd. (4934) | Komori